000 | 01079 a2200301 4500 | ||
---|---|---|---|
005 | 20250514173834.0 | ||
264 | 0 | _c20040507 | |
008 | 200405s 0 0 eng d | ||
022 | _a0269-8811 | ||
024 | 7 |
_a10.1177/0269881103174008 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBonelli, Raphael M | |
245 | 0 | 0 |
_aWhy minocycline is helpful in Huntington's disease. _h[electronic resource] |
260 |
_bJournal of psychopharmacology (Oxford, England) _cDec 2003 |
||
300 |
_a461 p. _bdigital |
||
500 | _aPublication Type: Letter | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 |
_aCognition _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHuntington Disease _xdrug therapy |
650 | 0 | 4 |
_aMinocycline _xpharmacology |
650 | 0 | 4 |
_aMotor Activity _xdrug effects |
700 | 1 | _aKapfhammer, Hans-Peter | |
773 | 0 |
_tJournal of psychopharmacology (Oxford, England) _gvol. 17 _gno. 4 _gp. 461 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/0269881103174008 _zAvailable from publisher's website |
999 |
_c14594221 _d14594221 |